SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Alimco Financial Corp

(Last)

(First)

(Middle)

2336 SE OCEAN BLVD

SUITE 400

(Street)

STUART

34996

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Kaspien Holdings Inc. [ KSPN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)	X	Other (specify below)
		Member of 10% owner group

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/11/2021		M		127,208	A	⁽¹⁾	152,893	I	By Alimco Re Ltd.
Common Stock	02/11/2021		F⁽²⁾		39	D	⁽¹⁾⁽²⁾	152,854	I	By Alimco Re Ltd.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Warrant for Common Stock	$0.01⁽¹⁾	02/11/2021		M			1	03/30/2020	03/31/2025	Common Stock	127,208	⁽³⁾	0	I	By Alimco Re Ltd.
Warrant for Common Stock	$0.01⁽⁴⁾	03/02/2022		P		1		03/02/2022	03/02/2027	Common Stock	320,000⁽⁴⁾⁽⁵⁾⁽⁶⁾	⁽⁶⁾	1	I	By Alimco Re Ltd.

Explanation of Responses:

1. The reported transaction involved the conversion by Alimco Re Ltd. of a warrant to purchase a total of 127,208 shares of Kaspien Holdings Inc. common stock at a price equal to $0.01 per share (the "2020 Warrant"). Alimco Re Ltd. is a wholly owned subsidiary of Alimco Financial Corporation ("Alimco"). Alimco may be deemed to have voting and dispositive control over shares held by Alimco Re Ltd. Alimco disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.

2. The 2020 Warrant was exercised on a cashless basis.

3. Alimco Re Ltd. acquired the 2020 Warrant in connection with a $2,718,000 secured term loan made on March 30, 2020 by Alimco Re Ltd. to Etailz Inc., a wholly owned subsidiary of Kaspien Holdings Inc.

4. The reported transaction involved the acquisition by Alimco Re Ltd. of a warrant to purchase a total of 320,000 shares of Kaspien Holdings Inc. common stock at a price equal to $0.01 per share (the "2022 Warrant").

5. Alimco disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein. This filing shall not be deemed an admission that Alimco is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any equity securities covered by this filing.

6. Alimco Re Ltd. acquired the 2022 Warrant in connection with a $5,000,000 secured term loan made on March 2, 2022 by Alimco Re Ltd. to Kaspien Inc., a subsidiary of Kaspien Holdings Inc.

	/s/ Jonathan Marcus, Chief Executive Officer	03/07/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.